Mahesh Anantha-Narayanan1, Rajkumar P Doshi2, Krunalkumar Patel3, Azfar Bilal Sheikh1, Fiorella Llanos-Chea1, Jinnette Dawn Abbott4, Mehdi H Shishehbor5, Raul J Guzman6, William R Hiatt7, Sue Duval8, Carlos Mena-Hurtado1, Kim G Smolderen1. 1. Vascular Medicine Outcomes (VAMOS) Program, Section of Cardiovascular Medicine, Yale University, New Haven, CT (M.A.-N., A.B.S., F.L.-C., C.M.-H., K.G.S.). 2. Department of Internal Medicine, University of Nevada Reno School of Medicine, Reno (R.P.D.). 3. Department of Internal Medicine, St Mary Medical Center, Langhorne, PA (K.P.). 4. Department of Medicine, Brown University and Rhode Island Hospital (J.D.A.). 5. Case Western Reserve University School of Medicine and University Hospital, Cleveland, OH (M.H.S.). 6. Division of Vascular Surgery, Yale-New Haven Hospital, CT (R.J.G.). 7. Division of Cardiology, University of Colorado School of Medicine and CPC Clinical Research, Aurora (W.R.H.). 8. Cardiovascular Division, University of Minnesota Medical School, Minneapolis (S.D.).
Abstract
BACKGROUND: Critical limb ischemia (CLI) morbidity and mortality rates have historically been disproportionately higher than for other atherosclerotic diseases, however, recent trends have not been reported. In patients admitted with CLI, we aimed to examine trends in in-hospital mortality, major amputations, length of stay, and cost of hospitalizations overall and stratified by type of revascularization procedures. METHODS: Using 2011 to 2017 National Inpatient Sample data, we identified CLI-related admissions based on International Classification of Diseases, Ninth and Tenth Edition, Clinical Modification codes. Primary outcomes of interest were in-hospital mortality and major amputations. Secondary outcomes were the length of stay and cost of hospitalization. We stratified outcomes based on endovascular or open surgical interventions. We also performed hierarchical multivariable regression analyses of outcomes based on age, sex, race, hospital size, type, and location. RESULTS: We identified 2 643 087 CLI-related admissions between 2011 and 2017. CLI admissions increased from 0.9% to 1.4% Ptrend<0.0001 as well as overall peripheral artery disease admissions (4.5%-8.9%, Ptrend<0.0001). In-hospital mortality for the entire CLI cohort decreased from 3.3% to 2.7%, Ptrend<0.0001, and major amputations decreased from 10.9% to 7%, Ptrend<0.0001. A decline was also noted for the length of stay from 5.7 (3.1-10.1) to 5.4 (3.0-9.2) days (Ptrend<0.0001), whereas admission costs increased from USD $11 791 ($6676-$21 712) to $12 597 ($7248-$22 748; Ptrend<0.0001). Endovascular interventions increased (Ptrend<0.0001) against a decline in surgical interventions (Ptrend<0.0001). Black race, female sex, and age ≥60 years were associated with higher in-hospital mortality, whereas Black race, male sex, and age<60 years were associated with higher major amputations. CONCLUSIONS: A relatively small decrease in absolute numbers for mortality and major amputations were observed against a backdrop of increasing CLI admissions over recent years. Patients with CLI received more endovascular interventions than surgical interventions over time. However, admissions for endovascular interventions were characterized by higher risk patient profiles and a higher risk of major amputations as compared with surgical interventions.
BACKGROUND:Critical limb ischemia (CLI) morbidity and mortality rates have historically been disproportionately higher than for other atherosclerotic diseases, however, recent trends have not been reported. In patients admitted with CLI, we aimed to examine trends in in-hospital mortality, major amputations, length of stay, and cost of hospitalizations overall and stratified by type of revascularization procedures. METHODS: Using 2011 to 2017 National Inpatient Sample data, we identified CLI-related admissions based on International Classification of Diseases, Ninth and Tenth Edition, Clinical Modification codes. Primary outcomes of interest were in-hospital mortality and major amputations. Secondary outcomes were the length of stay and cost of hospitalization. We stratified outcomes based on endovascular or open surgical interventions. We also performed hierarchical multivariable regression analyses of outcomes based on age, sex, race, hospital size, type, and location. RESULTS: We identified 2 643 087 CLI-related admissions between 2011 and 2017. CLI admissions increased from 0.9% to 1.4% Ptrend<0.0001 as well as overall peripheral artery disease admissions (4.5%-8.9%, Ptrend<0.0001). In-hospital mortality for the entire CLI cohort decreased from 3.3% to 2.7%, Ptrend<0.0001, and major amputations decreased from 10.9% to 7%, Ptrend<0.0001. A decline was also noted for the length of stay from 5.7 (3.1-10.1) to 5.4 (3.0-9.2) days (Ptrend<0.0001), whereas admission costs increased from USD $11 791 ($6676-$21 712) to $12 597 ($7248-$22 748; Ptrend<0.0001). Endovascular interventions increased (Ptrend<0.0001) against a decline in surgical interventions (Ptrend<0.0001). Black race, female sex, and age ≥60 years were associated with higher in-hospital mortality, whereas Black race, male sex, and age<60 years were associated with higher major amputations. CONCLUSIONS: A relatively small decrease in absolute numbers for mortality and major amputations were observed against a backdrop of increasing CLI admissions over recent years. Patients with CLI received more endovascular interventions than surgical interventions over time. However, admissions for endovascular interventions were characterized by higher risk patient profiles and a higher risk of major amputations as compared with surgical interventions.
Authors: Lindsey E Scierka; Carlos Mena-Hurtado; Mehdi H Shishehbor; John A Spertus; Sameer Nagpal; Trissa Babrowski; Matthew C Bunte; Amani Politano; Misty Humphries; Jayer Chung; Lee Kirksey; Olamide Alabi; Peter Soukas; Sahil Parikh; Rumi Faizer; Robert Fitridge; Jeremy Provance; Gaëlle Romain; Neil McMillan; Nancy Stone; Kate Scott; Christine Fuss; Christina M Pacheco; Kensey Gosch; Avis Harper-Brooks; Kim G Smolderen Journal: Int J Cardiol Heart Vasc Date: 2022-02-12
Authors: Monil Majmundar; Kunal N Patel; Rajkumar Doshi; Mahesh Anantha-Narayanan; Ashish Kumar; Grant W Reed; Rishi Puri; Samir R Kapadia; Ziad A Jaradat; Deepak L Bhatt; Ankur Kalra Journal: JAMA Netw Open Date: 2022-08-01